Ownership
Private
Employees
~100
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeBiologicCell therapyGene therapyMedical device (testing/services)

Absorption Systems General Information

Absorption Systems was a leading preclinical contract research organization specializing in ADMET/DMPK testing and bioanalysis for small molecules, biologics, cell/gene therapies, ophthalmic products, and medical devices. It developed innovative in vitro/in vivo models to predict human pharmacokinetics/toxicology outcomes. In November 2020 it was acquired by Pharmaron to expand global R&D service offerings.

Contact Information

Primary Industry
Drug Discovery Services
Corporate Office
Philadelphia, Pennsylvania
USA

Drug Pipeline

No pipeline data available

For full access to Absorption Systems's pipeline data

Book a demo

Key Partnerships

Collaborates with pharmaceutical companies, biotech firms, medical device manufacturers, regulatory agencies. Specific partnerships are generally confidential or client-based.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Absorption Systems Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Absorption Systems's complete valuation and funding history, request access »

Absorption Systems Financial Metrics